Itch and Pain Differences and Commonalities

作者: Martin Schmelz

DOI: 10.1007/978-3-662-46450-2_14

关键词: Nerve growth factorNeuroscienceNociceptionSpinal cordMedicineIn patientSensitizationChronic itchScratchingNociceptorAnesthesia

摘要: Pain and itch are generally regarded antagonistic as painful stimuli such scratching suppresses itch. Moreover, inhibition of pain processing by opioids generates further supporting their opposing role. Separate specific pathways for have been uncovered, several molecular markers established in mice that identify neurons involved the histaminergic non-histaminergic on primary afferent spinal level. These results agreement with specificity theory might suggest should be investigated separately level neurons, mediators, mechanisms. However, addition to broadly overlapping mediators pain, there is also evidence functions afferents: nociceptive afferents can provoke when activated very locally epidermis, sensitization both nociceptors pruriceptors has found following local nerve growth factor application volunteers. Thus, mechanisms underlie development chronic including spontaneous activity well cord may overlap a great extent. Rather than separating research concepts therefore address common Such an approach appears most appropriate clinical conditions neuropathic inflammatory conditions. While researchers benefit from large body information field, will find behavioral readouts much simpler those animals skin source pruritic more accessible even patients.

参考文章(89)
Vitaly Napadow, Ang Li, Marco L. Loggia, Jieun Kim, Peter C. Schalock, Ethan Lerner, Thanh-Nga Tran, Johannes Ring, Bruce R. Rosen, Ted J. Kaptchuk, Florian Pfab, The Brain Circuitry Mediating Antipruritic Effects of Acupuncture Cerebral Cortex. ,vol. 24, pp. 873- 882 ,(2014) , 10.1093/CERCOR/BHS363
J. A. Blunk, F. Seifert, M. Schmelz, P. W. Reeh, W. Koppert, Injection pain of rocuronium and vecuronium is evoked by direct activation of nociceptive nerve endings. European Journal of Anaesthesiology. ,vol. 20, pp. 245- 253 ,(2005) , 10.1017/S0265021503000413
M. Toyoda, M. Nakamura, T. Makino, T. Hino, M. Kagoura, M. Morohashi, Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis British Journal of Dermatology. ,vol. 147, pp. 71- 79 ,(2002) , 10.1046/J.1365-2133.2002.04803.X
Martin Steinhoff, Ulrich Neisius, Akihiko Ikoma, Manigé Fartasch, Gisela Heyer, Per S Skov, Thomas A Luger, Martin Schmelz, None, Proteinase-Activated Receptor-2 Mediates Itch: A Novel Pathway for Pruritus in Human Skin The Journal of Neuroscience. ,vol. 23, pp. 6176- 6180 ,(2003) , 10.1523/JNEUROSCI.23-15-06176.2003
M. R. Tramèr, F. Kjellberg, Pharmacological control of opioid-induced pruritus: a quantitative systematic review of randomized trials European Journal of Anaesthesiology. ,vol. 18, pp. 346- 357 ,(2001) , 10.1046/J.0265-0215.2000.00826.X
Sorin J. Brull, Peter G. Atanassoff, David G. Silverman, Junming Zhang, Robert H. Lamotte, Attenuation of experimental pruritus and mechanically evoked dysesthesiae in an area of cutaneous allodynia Somatosensory and Motor Research. ,vol. 16, pp. 299- 303 ,(1999) , 10.1080/08990229970366
Nancy E. Lane, Thomas J. Schnitzer, Charles A. Birbara, Masoud Mokhtarani, David L. Shelton, Mike D. Smith, Mark T. Brown, Tanezumab for the Treatment of Pain from Osteoarthritis of the Knee The New England Journal of Medicine. ,vol. 363, pp. 1521- 1531 ,(2010) , 10.1056/NEJMOA0901510
Xavier Chevalier, Florent Eymard, Pascal Richette, Biologic agents in osteoarthritis: hopes and disappointments. Nature Reviews Rheumatology. ,vol. 9, pp. 400- 410 ,(2013) , 10.1038/NRRHEUM.2013.44
H. Kumagai, T. Ebata, K. Takamori, T. Muramatsu, H. Nakamoto, H. Suzuki, Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study Nephrology Dialysis Transplantation. ,vol. 25, pp. 1251- 1257 ,(2010) , 10.1093/NDT/GFP588